Search Results - di+xia

1 Results

Sort By:

Monoclonal Antibody (RO4) that Reacts with the Juxta-membrane Region of Mesothelin

Summary: The National Cancer Institute (NCI) seeks research co-development partners and/or licensees for a novel monoclonal antibody (mAb), RO4, that can be used to treat mesothelin (MSLN) expressing cancers. Description of Technology: Mesothelin (MSLN) is a surface antigen highly expressed in many solid tumors, such as mesothelioma, ovarian, and...

Published: 7/1/2026 | Updated: 7/1/2026 | Inventor(s): Ira Pastan, Mitchell Ho, Masanori Onda, Di Xia, Xiu Fen Liu

Keywords(s):

Category(s): Collaboration Sought > Licensing, Collaboration Sought > Collaboration, Application > Therapeutics, TherapeuticArea > Oncology, TherapeuticArea > Immunology